Drawing for DOSEID CERTIFIED

USPTO serial 90813524

DOSEID CERTIFIED

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HOPKINS, SARAH COLLEEN
Law office
TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DOSEID CERTIFIED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashly Boesche

Ashly Boesche Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 S. Wacker Drive, Suite 2900Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
ASerialized and radio-frequency identification (RFID) tagged pharmaceuticals, pharmaceutical preparations, and medical supplies; Radio-frequency identification (RFID) tags; Labels for pharmaceuticals, pharmaceutical preparations, and medical supplies; Radio-frequency identification (RFID) scanning readers for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Computer hardware and operating software for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Computer hardware and operating software for clinical decision supportACTIVE—
BProviding temporary use of non-downloadable computer software for tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Providing temporary use of non-downloadable computer software for auditing medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with auditing medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Providing authentication and verification services using computer hardware and software for pharmaceuticals, pharmaceutical preparations, medical dispensing systems, and medical supplies; Developing and maintaining a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, pharmaceutical preparations, medication dispensing systems, and medical supplies; Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, pharmaceutical preparations, medication dispensing systems, and medical supplies; Computer software licensingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 11, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 11, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 11, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 26, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2022DOCKASSIGNED TO EXAMINER—
Nov 12, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 12, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 12, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 3, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 3, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 3, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 3, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 25, 2021WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Oct 25, 2021WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Oct 22, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 22, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 16, 2021MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance